STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.

Borry R, Vilcot F, Tesson B, Moraly J, Fabiole E, Boullé A, Aid Z, Puig Lombardi ME, Sellami R, Degoutte C, Darchen A, Veleanu L, Heintzé M, Panunzi L, As M, Giovannangeli C, Cagnard N, Asnafi V, Lhermitte L, Couronné L, Surdez D, Muller K, Pasquier E, Le Grand M, Revy P, Mercher T, Lamant L, Babin L, Meggetto F, Sibon D, Brunet E

Open source

DOI: 10.1182/blood.2025032902
Published: 2026 Oct 5
Container: Blood
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025032902,
  title = {STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.},
  author = {Borry R and Vilcot F and Tesson B and Moraly J and Fabiole E and Boullé A and Aid Z and Puig Lombardi ME and Sellami R and Degoutte C and Darchen A and Veleanu L and Heintzé M and Panunzi L and As M and Giovannangeli C and Cagnard N and Asnafi V and Lhermitte L and Couronné L and Surdez D and Muller K and Pasquier E and Le Grand M and Revy P and Mercher T and Lamant L and Babin L and Meggetto F and Sibon D and Brunet E},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025032902},
  url = {https://doi.org/10.1182/blood.2025032902}
}

RIS

TY  - JOUR
TI  - STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.
AU  - Borry R
AU  - Vilcot F
AU  - Tesson B
AU  - Moraly J
AU  - Fabiole E
AU  - Boullé A
AU  - Aid Z
AU  - Puig Lombardi ME
AU  - Sellami R
AU  - Degoutte C
AU  - Darchen A
AU  - Veleanu L
AU  - Heintzé M
AU  - Panunzi L
AU  - As M
AU  - Giovannangeli C
AU  - Cagnard N
AU  - Asnafi V
AU  - Lhermitte L
AU  - Couronné L
AU  - Surdez D
AU  - Muller K
AU  - Pasquier E
AU  - Le Grand M
AU  - Revy P
AU  - Mercher T
AU  - Lamant L
AU  - Babin L
AU  - Meggetto F
AU  - Sibon D
AU  - Brunet E
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025032902
UR  - https://doi.org/10.1182/blood.2025032902
ER  -

APA

R, B., F, V., B, T., J, M., E, F., A, B., Z, A., ME, P. L., R, S., C, D., A, D., L, V., M, H., L, P., M, A., C, G., N, C., V, A., L, L., L, C., D, S., K, M., E, P., M, L. G., P, R., T, M., L, L., L, B., F, M., D, S., & E, B. (2026). STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.. Blood. https://doi.org/10.1182/blood.2025032902

Source records

pubmed · retrieved 2026-11-10T15:06:23.830Z